… study was to compare the pharmacokinetic characteristics of a new and a branded citalopram
20 mg formulation to support the marketing authorization of the test formulation in China. …

… Citation3 Escitalopram is a single S-enantiomer of citalopram… on a 12-month open-label
study of 486 patients treated with … of CYP2C19 poor metabolizers (PMs) within the Chinese …

… , the impact of CYP2C19 polymorphisms on citalopram or … citalopram 40 mg or escitalopram
20 mg being administered [3, 4]. Both citalopram and escitalopram are primarily metabolized …

… [39] had conducted a conventional bioequivalence study in 24 healthy CYP2C19 … branded
citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study …

… male volunteers and evaluate whether a generic tablet of … healthy Chinese volunteers was
eligible for this 6 mg single dose, randomized-sequence, open-label, 2-period crossover study…

… pharmacokinetic determinants, including extent of absorption, body … metabolized by
CYP2C9, CYP2C19, or CYP2D6, and … were > 1, ranging from 1.04 (citalopram) to 2.94 (omeprazole), …

… the generic (test) formulation containing tianeptine sodium 12.5 mg and the branded (…
A randomized, two-sequence, two-treatment crossover study was conducted in healthy male …

… bioequivalence between generic and brand-name drugs is established by comparing their
bioavailability. … the packaging or pill colour/shape is different to that of the branded drug [18]. …

… study, the pharmacokinetics of the transdermal CTH delivery system were analyzed in rabbits.
The results showed that the system had good absorption … dosage range (20 mg to 40 mg) […

… of 30 mg citalopram, which is within the dose range (20–60mg) … Pharmacokinetic and plasma
hormone concentration studies have … bioavailability comparison of generic and branded …